- Home
- ACNT vs BDTX Comparison
ACNT vs BDTX Comparison
Compare ACNT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACNT | BDTX |
|---|---|---|
| Founded | 1945 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.5M | 148.1M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACNT | BDTX |
|---|---|---|
| Price | $16.56 | $2.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 53.7K | ★ 932.0K |
| Earning Date | 03-03-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.09 | ★ 0.38 |
| Revenue | ★ $171,413,000.00 | $70,000,000.00 |
| Revenue This Year | $22.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $176.82 | ★ $7.28 |
| Revenue Growth | ★ 65.05 | N/A |
| 52 Week Low | $10.76 | $1.20 |
| 52 Week High | $16.84 | $4.94 |
Technical Indicators
Market Signals| Indicator | ACNT | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.90 | 50.55 |
| Support Level | $15.97 | $2.56 |
| Resistance Level | $16.59 | $2.88 |
| Average True Range (ATR) | 0.33 | 0.14 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 83.87 | 85.43 |
Price Performance
Historical ComparisonAbout ACNT Ascent Industries Co.
Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.